Modelling the risk of visual field loss arising from long-term exposure to the antiepileptic drug vigabatrin: a cross-sectional approach.

Wild, John M; Fone, David L; Aljarudi, Saleh; Lawthom, Charlotte; Smith, Philip E M; Newcombe, Robert G; Lewis, Gareth D

Wild, John M; Fone, David L; Aljarudi, Saleh; Lawthom, Charlotte; Smith, Philip E M; Newcombe, Robert G; Lewis, Gareth D.

Affiliation

Wild JM; Cardiff Centre for Vision Sciences, College of Biomedical and Life Sciences, Cardiff University, Maindy Road, Cardiff, Wales, CF24 4HQ, UK, wildjm@cardiff.ac.uk.

CNS Drugs ; 27(10): 841-9, 2013 Oct.

Article in En | MEDLINE | ID: mdl-23990316

Subject(s)

Anticonvulsants/adverse effects; Vigabatrin/adverse effects; Visual Fields/drug effects; Adult; Anticonvulsants/administration & dosage; Anticonvulsants/therapeutic use; Cohort Studies; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Humans; Male; Retrospective Studies; Risk Assessment; Time Factors; Vigabatrin/administration & dosage; Vigabatrin/therapeutic use; Visual Field Tests

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Visual Fields / Vigabatrin / Anticonvulsants Type of study: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: CNS Drugs Journal subject: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google